Lexicon to Use BioSeek Tools for Drug Discovery | GenomeWeb
NEW YORK (GenomeWeb News) – BioSeek said today that Lexicon Pharmaceuticals will use the firm’s BioMAP systems to evaluate selected compounds associated with Lexicon’s drug discovery programs.
 
The BioMAP systems use predictive primary human cell-based disease models that generate profiles for drug candidates.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.